were synthesized. Substituted o-phenylenediamine was reacted with substituted 4-cyanobenzaldehydes in the presence of sodium metabisulfite to furnish substituted 2-(4-cyanophenyl)-1H-benzimidazoles (1). When these substituted 2-(4-cyanophenyl)-1H-benzimidazoles were further treated with ethyl chloroacetate in KOH/DMSO, N-alkylated product (2-(4-cyanophenyl)-benzimidazol-1-yl)-acetic acid ethyl esters (2) was formed. To synthesize 2-(4-cyanophenyl)-benzimidazol-1-yl)-acetic acid hydrazides (3) chemical reactions were conducted between hydrazine hydrate and the esters (2). When a mixture of 2-(4-cyanophenyl)-benzimidazol-1-yl)-acetic acid hydrazide (3) react with substituted aldehydes in ethanol was reflusk, imines intermediates [4(I-XXXI)] was formed. To synthesize 9(I-XXXI) reactions were occurred between a mixture of imine intermediate and thioglycollic acid in dioxane. The structures of newly synthesized compounds 9(I-XXXI) was confirmed by spectroscopic techniques. All the synthesized compounds were screened for its in vitro antioxidant and antiinflammatory activity. The in vitro antioxidant and antiinflammatory activity might be attributed due to the presence of more electrons withdrawing group and moiety having more lipophilicity also more electronegativity in nature. Asian Journal of Chemistry; Vol. 26, No. 24 (2014), have suggested that rofecoxib's adverse cardiovascular events may not be a class effect but rather an intrinsic chemical property related to its metabolism 10 . Literature survey make known that the thiazolidinone moiety as it was an important scaffold for COX-2 inhibition [11][12][13] . In the present study whatever thiazolidinone-4-one derivatives was synthesized which may not have the irritation to the gastric mucosa also which may not cause additional damage to the gastrointestinal tract. Thiazolidin-4-ones are an interesting backbone unit in medicinal chemistry and responsible for numerous pharmacological properties and biological activity [14][15][16][17][18][19] which gives the considerable research interest in this area has been done towards the synthesis of thiazolidinone unit. In addition, several interesting investigations have been made through thiazolidin-4-ones based heterocyclic compounds and exhibited numerous biological properties such as antibacterial, antifungal, antitumor, antiarrhythmic, antithrombic, calcium antagonist, hypotensive and neuroleptic activities. An essential component of the search for new leads in drug designing program is the synthesis of molecules, which are novel still resemble known biologically active molecule by virtue of the 20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38   39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 2 17788 presence of some pharmacophoric groups. Certain small heterocyclic molecules act as highly functionalized scaffolds and are known pharmacophores of a number of biologically active and useful molecules. Benzimidazole derivatives are well known for their antiinflammatory activity and more recently have been discovered to have anticancer effect 20,21 . Therefore, in the present paper we planned to incorporate the benzimidazole moiety with thiazolidin-4-ones to have better antioxidant and antiinflammatory activity.
INTRODUCTION
The structural and therapeutic diversity coupled with commercial viability of small molecules has fascinated organic and medicinal chemists. There has been considerable interest in the chemistry of thiazolidin-4-one ring systems, which is a core structure in various synthetic pharmaceuticals displaying a broad spectrum of biological activity 1 such as anti-mycobacterial 2 , anti-fungal 3 , anti-cancers 4 , anti-convulsant 5 , antiinflammatory and analgesic 6 activities. Therefore, a general, simple and efficient method for rapid synthesis of thiazolidine-4-ones would be greatly advantageous and warrants further investigations in drug discovery. Consequently, many different protocols have been developed that allow the synthesis of thiazolidin-4-one skeletons. Their long-term clinical employment is associated with significant side effects and the steady use determines the onset of gastrointestinal lesions, bleeding and nephrotoxicity Asian Journal of Chemistry; Vol. 26, No. 24 (2014) , have suggested that rofecoxib's adverse cardiovascular events may not be a class effect but rather an intrinsic chemical property related to its metabolism 10 . Literature survey make known that the thiazolidinone moiety as it was an important scaffold for COX-2 inhibition [11] [12] [13] . In the present study whatever thiazolidinone-4-one derivatives was synthesized which may not have the irritation to the gastric mucosa also which may not cause additional damage to the gastrointestinal tract. Thiazolidin-4-ones are an interesting backbone unit in medicinal chemistry and responsible for numerous pharmacological properties and biological activity [14] [15] [16] [17] [18] [19] which gives the considerable research interest in this area has been done towards the synthesis of thiazolidinone unit. In addition, several interesting investigations have been made through thiazolidin-4-ones based heterocyclic compounds and exhibited numerous biological properties such as antibacterial, antifungal, antitumor, antiarrhythmic, antithrombic, calcium antagonist, hypotensive and neuroleptic activities. An essential component of the search for new leads in drug designing program is the synthesis of molecules, which are novel still resemble known biologically active molecule by virtue of the 20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38   39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 2 17788 presence of some pharmacophoric groups. Certain small heterocyclic molecules act as highly functionalized scaffolds and are known pharmacophores of a number of biologically active and useful molecules. Benzimidazole derivatives are well known for their antiinflammatory activity and more recently have been discovered to have anticancer effect 20, 21 . Therefore, in the present paper we planned to incorporate the benzimidazole moiety with thiazolidin-4-ones to have better antioxidant and antiinflammatory activity.
L L E Y P R O O F

EXPERIMENTAL
Melting points were determined by open capillary method and were uncorrected. The IR spectra (in KBr) were recorded on a Shimadzu IR Affinity-1 spectrophotometer. 1 H NMR and 13 CNMR spectra were recorded on a Perkin-Elmer EM 300 MHz spectrometer using TMS as internal standard. The mass spectra were recorded on a JEOL JMS-D 300 spectrometer operating at 70 eV. Purity of the compounds was checked by TLC silica coated plates obtained from Merck.
General procedure: For the preparation of 2-[2-(4-cyanophenyl)-6-substituted-1H-benzimidazol-1-yl]-N-[2-(substituted)-4-oxo-1,3-thiazolidin-3-yl] acetamide [9(I-XXXI)]
A mixture of imine intermediate [4(I-XXXI)] (0.01 mole) and thioglycollic acid (0.01 mole) in 15 mL dioxane was refluxed at 115 °C for 24 h. The reaction mixture was triturated with 10 % sodium bicarbonate solution. The neutral solution was poured into crushed ice. The solid formed was collected by filtration, washed with water and dried. The product was crystallized from methanol to give 9(I-XXXI). The purity of the compounds was established by single spot on TLC plates. The physico-chemical characteristic data is given in Table-1 Biological evaluation: Antioxidant and free radical scavenging activity assays.
DPPH assay: This experimental procedure was adapted from 22 . In an ethanol solution of 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical, test compounds at different concentrations were added. The reaction mixtures were shaken vigorously and then kept in the dark for 0.5 h. The absorbance of the resulting solutions was measured in 1 cm cuvettes, using a UV/visible spectrophotometer at 226 nm against blank without DPPH. Decreasing of DPPH solution absorbance indicates an increase of DPPH radical scavenging activity. This activity is given as % DPPH radical scavenging that is calculated in the equation:
Absorbance of control Absorbance of test Inhibition (%) 100 Absorbance of control
The DPPH solution without sample solution was used as control. All tests were run in triplicate and averaged. Ascorbic acid was used as positive control.
in vitro Anti-inflammatory activity Inhibition of protein denaturation method: Test solution (0.5 mL) consists of 0.45 mL of BSA (5 % w/v aqueous solution) and 0.05 mL of different concentration of test solutions (50, 100, 150, 200 µg/mL). Test control solution (0.5 mL) consists of 0.45 mL of BSA (5 % w/v aqueous solution) and 0.05 mL of distilled water. Product control solution (0.5 mL) consists of 0.45 mL of distilled water and 0.05 mL of different concentration of test solutions (50, 100, 150, 200 µg/mL). Standard solution (0.5 mL) consists of 0.45 mL of BSA (5 % w/v aqueous solution) and 0.05 mL different concentration of diclofenac sodium's (50, 100, 150, 200 µg/mL). All the above solutions were adjusted to pH 6.3 using 1N hy- 
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drochloric acid. The samples were incubated at 37 °C for 20 min and the temperature was increased to keep the samples at 57 °C for 3 min. After cooling, 2.5 mL of phosphate buffer saline was added to the above solutions. The absorbance was measured using UV-visible spectrophotometer at 416 nm 23 . The percentage inhibition of protein denaturation was calculated as,
in vitro Anti-inflammatory activity Cyclooxygenase (COX) inhibitor screening assay: The inhibitory activities against COX-1 and COX-2 were determined using a colourimetric COX (ovine) inhibitor assay kit (Cayman Chemical Co., Cat. No. 760111) according to the manufacturer's protocol 24, 25 . The inhibitory activities of the compounds were measured by monitoring the production of oxidized N,N,N',N'-tetramethyl-p-phenylenediamine (TMPD) at 405 nm followed by incubation of either ovine COX-1 or COX-2 with arachidonic acid. The enzymes were preincubated for 5 min at 25 °C with the test compounds prior to addition of arachidonic acid (final concentration 1.1 mM) and TMPD and incubation for 5 min at 25 °C. The COX-inhibiting activity was calculated according to the equation.
COX inhibiting activity (%) = [1-(A1-A2)/A0] × 100 where A0 was the absorbance of the control (without the test compound), A1 was the absorbance in the presence of the test compound and A2 was the absorbance sample blank (without TMPD). The IC50 is the concentration of tested compounds reducing 50 % of ovine COX-1 or COX-2 under the given experimental conditions and was calculated using a calibration curve with different concentrations of samples.
L L E Y P R O
RESULTS AND DISCUSSION
For the synthesis of target compounds the reaction sequences outlined in Scheme-1 were followed. 2-[2-(4-cyanophenyl)-6-substituted-1H-benzimidazol-1-yl]-N-[2-(substituted)-4-oxo-1,3-thiazolidin-3-yl]acetamide [9(I-XXXI)] were synthesized employing conventional techniques. Substituted o-phenylenediamine was reacted with appropriately 4-cyanobenzaldehydes in the presence of sodium metabisulfite to furnish substituted 2-(4-cyanophenyl)-1H-benzimidazoles (1). These substituted 2-(4-cyanophenyl)-1H-benzimidazoles were further treated with ethyl chloroacetate in KOH/DMSO gave the N-alkylated product, (2-(4- 
. 
. Compounds 9(XIX) (160 ± 0.881) µg/mL, 9(XX) (108 ± 1.04) µg/mL and 9(XXVI) (165 ± 0.884) µg/mL were highly active at low concentration and compounds 9(VI) (264 ± 0.975) µg/mL, 9(XVII) (396 ± 0.949) µg/mL, 9(XVIII) (283 ± 1.029) µg/mL, 9(XXII) (186 ± 1.04) µg/mL, 9(XXIII) (325 ± 0.934) µg/mL and 8(XXX) (181 ± 1.18) µg/mL were moderately active at higher concentration as compared to ascorbic acid (109 ± 0.7296) µg/mL in free radical scavenging activity by 2,2-diphenyl-1-picryl hydrazide assay method in Table- in vitro Antiinflammatory by inhibition of protein denaturation method the compounds 9(VI) (68.26 ± 0.9514) µg/ mL, 9(XXII) (72.76 ± 0.97) µg/mL and 9(XXX) (75.67 ± 0.92) µg/mL were found to be highly active in low concentration and compounds 9(XVII) (110.1 ± 0.9765) µg/mL, 9(XVIII) (86.7 ± 1.0225) µg/mL, 9(XIX) (108.4 ± 0.87) µg/ mL, 9(XX) (93 ± 0.725) µg/mL, 9(XXIII) (92.03 ± 1.022) µg/mL, 9(XXVI) (92.12 ± 1.03) µg/mL and 9(XXXI) (87.35 ± 0.786) µg/mL were found to be moderately active at higher concentration as compared to diclofenac sodium (57.08 ± 0.7296) µg/mL in Table-3 . The results may be attributes due to the presence of more electrons withdrawing group and moiety having more lipophilicity also more electro negativity in nature, good antioxidant and antiinflammatory properties.
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5.12 ± 0.13 µg/mL, respectively. The replacement of the more lipophilic chloro substituent by the less lipophilic nitro group, leads to a decrease of COX-1 inhibitory activity in the case of compounds 9(III) and 9(XXI) substituted derivatives (8.67 ± 0.17 µg/mL and 18.99 ± 0.15 µg/mL, respectively). Replacement of the 2-Br, 5-OH benzaldehyde derivative and 2,5-dihydroxy benzaldehyde derivative with 4,5-dichloro benzaldehyde derivative, 3-Cl benzaldehyde derivative and 2-OCH3 benzaldehyde derivative resulted in obtaining compounds with increased activity at low concentration (compounds 9(XVI), 9(VII), 9(VI), 9(IX) and 9(XIV), 23.6 ± 0.12, 17.65 ± 0.13, 8.65 ± 0.16, 8.06 ± 0.18 and 8.39 ± 0.12 µg/mL, respectively), as compared to indomethacin (1.44 ± 0.17 µg/mL) in Table-4. Other compounds were considered to be less active or inactive.
All the newly synthesized compounds 9(I-XXXI) were screening for inhibitory effect on ovine COX-2 activity in vitro. It was observed that among the thiazolidinone derivatives fluro, chloro and methoxy substitution is more favourable
exhibited the highest COX-2 inhibition at low concentration (3.597 ± 0.14 µg/mL), followed by 2-
4.835 ± 0.12 µg/mL, respectively. The replacement of the more lipophilic chloro substituent by the less lipophilic nitro group, leads to a decrease of COX-1 inhibitory activity in the case of 9(III) and 9(XXI) substituted derivatives (7.821 ± 0.16 and 18.17 ± 0.14 µg/mL, respectively). Replacement of the 2-Br, 5-OH benzaldehyde derivative and 2,5-dihydroxy benzaldehyde derivative with 4,5-dichloro benzaldehyde derivative, 3-Cl benzaldehyde derivative and 2-OCH3 benzaldehyde derivative resulted in obtaining compounds with increased activity at low concentration (compounds 9(XVI), 9(VII), 9(IX), 9(VI) and 9(XIV), 22.4 ± 0.11, 16.64 ± 0.12, 7.792 ± 0.17, 7.736 ± 
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Introduction
The structural and therapeutic diversity coupled with commercial capability of small molecules has enthralled organic and medicinal chemists. There has been significant interest in the chemistry of oxadiazole ring systems, which is a core structure in various synthetic pharmaceuticals displaying a broad spectrum of biological activity. In the past few years, research for new non-steroidal anti-inflammatory agents has been reported that many compounds having a 1,3,4-oxadiazole derivatives are known for their anti-inflammatory activity. [1] [2] [3] Oxadiazole derivatives play a significant role in various pharmaceuticalapplications. [4] [5] [6] As an important class of heterocyclic compound, 1,3,4-oxadiazoles show broad spectrum of biological activities. [7] [8] [9] [10] [11] [12] Among these, a few differently substituted1,3,4-oxadiazoles have exhibited potent antitumor activities particularly. [13] [14] [15] Of the various human diseases, cancer has proven to be one of the most intractable diseases to which humans are subjected, and as yet no practical and generally effective drugs or methods of control are available. Therefore, identification of novel potent, selective and less toxic anti-cancer agent's remains one of the most pressing health problems. 16 Targeting tubulin in rapidly dividing tumor cells has been a well validated strategy for cancer therapy. 17, 18 Benzimidazole derivatives are well known for their anti-inflammatory activity and more recently have been discovered to have anticancer effect. 19, 20 Therefore, in the present research it was planned to incorporate the Benzimidazole moiety with 1,3,4-oxadiazole to have better antioxidant and anti-inflammatory activity.
Materials and methods
Chemistry
Melting points were determined by open capillary method and were uncorrected. The IR spectra (in KBr) were recorded on a Shimadzu IR Affinity-1 spectrophotometer. 1 H NMR and 13 CNMR spectra were recorded on a Perkin-Elmer EM 300 MHz spectrometer using TMS as internal standard. The mass spectra were recorded on a JEOL JMS-D 300 spectrometer operating at 70 eV. Purity of the compounds was checked by TLC silica coated plates obtained from Merck. To a solution of imine intermediate 5 (V-XXXIII) (0.01 mole) in ethanol (15 ml) and Chloramines-T (0.01 mole) was added. The reaction mixture was exposed to microwave at 300 W intermittently at 30 sec intervals for specified time. After complete conversion as indicated by TLC, the reaction mixture was cooled and digested with cold water.
Biological Evaluation
3.1. Antioxidant and free radical scavenging activity assays
DPPH assay
This experimental procedure was adapted from. 21 In an ethanol solution of 2, 2-diphenyl-1-picrylhydrazyl (DPPH) radical, test compounds at different concentrations were added. The reaction mixtures were shaken vigorously and then kept in the dark for 30 min. The absorbance of the resulting solutions was measured in 1 cm cuvettes, using a UV/VIS spectrophotometer at 351nm against blank without DPPH. Decreasing of DPPH solution absorbance indicates an increase of DPPH radical scavenging activity. This activity is given as % DPPH radical scavenging that is calculated in the equation: The DPPH solution without sample solution was used as control. All tests were run in triplicate and averaged. Ascorbic acid was used as positive control in (Table 2 and Figure 2 ).
3.2.
In vitro anti-inflammatory activity 
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samples at 57 0 C for 3 min. After cooling, 2.5 mL of phosphate buffer saline was added to the above solutions. The absorbance was measured using UV Visible spectrophotometer at 417 nm. 22 The percentage inhibition of protein denaturation was calculated as,
The results were compared with Diclofenac Sodium in (Table 3 and Figure 3 ). 
Results and discussion
For the synthesis of the target compounds the reaction sequences outlined in Scheme 1, were followed. 5-(2-ethoxy-4-methoxyphenyl)-1,3,4-oxadiazol-2-yl) 57, 60, 95, 107, 112, 114, 119, 120, 121, 131, 134, 136, 141, 142, 144, 145, 149 The compound 7.XX (116±1.025) µg/ml and 7.XXIX (103±0.96) µg/ml were found to be highly active in low concentration and compounds 7.VIII (160±0.9614) µg/ml, 7.IX (300±0.9865) µg/ml, 7.X (220±1.0425) µg/ml, 7.XIX (165±0.67) µg/ml, 7.XXII (147±0.96) µg/ml, 7. XXIV (148±1.052) µg/ml and 7.XXV (137±1.16) µg/ml were found to be moderately active at higher concentration as compared to ascorbic acid (109±0.7296) µg/ml in 2, 2-diphenyl-1-picryl hydrazide method. In-vitro anti-inflammatory by inhibition of protein denaturation method the compounds 7.VIII (64.98±1.154701) µg/ml, 7.XX (67.59±0.8819171) µg/ml, 7.XXII (61.02±1.20185) µg/ml and 7.XXIX (67.5±0.9865) µg/ml were found to be highly active in low concentration and compounds 7.V (137.4±0.881917), 7.VI (119.8±1.527525), 7.X (76.77±0.5773503) µg/ml, 7.XIX (86.48±0.5773503) µg/ml, 7. XXIV (99.56±1.154701) µg/ml, 7.XXV (99.16±0.8819171) µg/ml and 7.XXVIII (100±0.5773503) µg/ml were found to be moderately active at higher concentration as compared to diclofenac sodium (57.08±0.8819) µg/ml.
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INTRODUCTION
The structural and therapeutic diversity coupled with commercial capability of small molecules has enthralled organic and medicinal chemists. There has been significant interest in the chemistry of triazole ring systems, which is a core structure in various synthetic pharmaceuticals displaying a broad spectrum of biological activity. In the past few years, research for new non-steroidal anti-inflammatory agents has been reported that many compounds having a 1,2,4-triazole derivatives are known for their anti-inflammatory activity [1] [2] [3] [4] [5] [6] .
From the literature survey it was found that, depending on the type of substituent, the derivatives of 1, 2, 4-triazole has a high potential for biological activity, possessing a wide range of antimicrobial [7] [8] [9] [10] and antitumor [11] [12] [13] [14] properties. The other triazole derivatives show anti-inflammatory [15] , antihypertensive [16] , anticonvulsant, antiviral [17] and analgesic activities [18] .
Also a number of benzimidazole derivatives were identified as potent analgesic and anti-inflammatory compounds [19, 20] .
Therefore, in the present paper it was planned to incorporate the benzimidazole moiety with 1, 2, 4-triazole to have better antioxidant and anti-inflammatory activity.
MATERIALS AND METHODS
Chemistry
Melting points were determined by open capillary method and were uncorrected. The IR spectra (in KBr) were recorded on a Shimadzu IR Affinity-1 spectrophotometer. 1 H NMR and 13 CNMR spectra were recorded on a Perkin-Elmer EM 300 MHz spectrometer using TMS as internal standard. The mass spectra were recorded on a JEOL JMS-D 300 spectrometer operating at 70 eV. Purity of the compounds was checked by TLC silica coated plates obtained from Merck. All characterization data are mention in Table 1 . The mixture of 2-(4-cyanophenyl)-benzimidazol-1-yl)-acetic acid hydrazide (3) (0.1 mol) in acetic acid (20 ml), a pinch of ammonium acetate was added followed by the addition of aromatic aldehydes (0.1 mol). The mixture was stirred for 24 hr. at room temperature.
The mother liquor on neutralization with sodium bi-carbonate solution gave a solid, which was filtered and recrystallized from ethanol.
Biological Evaluation
Radical scavenging assays by the DPPH
This experimental procedure was adapted from [21] . In an ethanol solution of 2, 2-diphenyl-1-picrylhydrazyl (DPPH) radical, test compounds at different concentrations were added. The reaction mixtures were shaken vigorously and then kept in the dark for 30 min. The absorbance of the resulting solutions was measured in 1 cm cuvettes, using a UV/VIS spectrophotometer at 328nmagainst blank without DPPH. Decreasing of DPPH solution absorbance indicates an increase of DPPH radical scavenging activity. This activity is given as % DPPH radical scavenging that is calculated in the equation:
Percentage inhibition = Absorbance of control -Absorbance of test Absorbance of control X 100 .
The DPPH solution without sample solution was used as control. All tests were run in triplicate and averaged. Ascorbic acid was used as positive control in Table 2 and Figure 2 .
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In vitro anti-inflammatory activity by inhibition of protein denaturation method
Test solution (0.5 mL) consists of 0.45 mL of BSA (5% w/v aqueous solution) and 0.05 mL of different concentration of test solutions (50, 100, 150, 200 µg/mL). Test control solution (0.5 mL) consists of 0.45 mL of BSA (5% w/v aqueous solution) and 0.05 mL of distilled water. Product control solution (0.5 mL) consists of 0.45 mL of distilled water and 0.05 mL of different concentration of test solutions (50, 100, 150, 200 µg/mL). Standard solution (0.5 mL) consists of 0.45 mL of BSA (5%w/v aqueous solution) and 0.05 mL different concentration of Diclofenac Sodium's (50, 100, 150, 200 µg/ mL). All the above solutions were adjusted to pH 6.3 using 1N hydrochloric acid. The samples were incubated at 37 0 C for 20 min and the temperature was increased to keep the samples at 57 0 C for 3 min. After cooling, 2.5 mL of phosphate buffer saline was added to the above solutions. The absorbance was measured using UV Visible spectrophotometer at 416 nm [22] . The percentage inhibition of protein denaturation was calculated as,
The results were compared with Diclofenac Sodium in Table 3 and Figure 3 .
RESULTS AND DISCUSSION
For the synthesis of the target compounds the reaction sequences outlined in Scheme 1,werefollowed. .6666) µg/ml were found to be moderately active at higher concentration as compared to diclofenac sodium (57.08±0.7296) µg/ml. The results may be attributes due to the presence of more electrons withdrawing group and moiety having more lipophilicity also more electro negativity in nature.
ISSN: 0975-8585
November -December 2014 RJPBCS 5(6) Page No. 251 
